 | • レポートコード：D0804-09153 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、108ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、核酸ワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。核酸ワクチンの種類別市場規模（予防用核酸ワクチン、治療用核酸ワクチン）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Moderna、Zhifei Shengwu、Sanofi、CureVac、Hualan Bio、Inovio、BioKangtai、CNBG、GSK、Liaoning Chengda、CanSinoBIO、Walvax Biotechnology、Fosun Pharma ・地域別グローバル市場分析 2015年-2020年 ・核酸ワクチンの北米市場（アメリカ、カナダ、メキシコ） ・核酸ワクチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・核酸ワクチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・核酸ワクチンの南米市場（ブラジル、アルゼンチン） ・核酸ワクチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：予防用核酸ワクチン、治療用核酸ワクチン ・用途別分析：病院、クリニック、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Nucleic Acid Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Nucleic Acid Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
This report also the impact of Covid-19 outbreak on the Nucleic Acid Vaccine industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Nucleic Acid Vaccine and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Nucleic Acid Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Nucleic Acid Vaccine market has been segmented into
Preventive Nucleic Acid Vaccine
Therapeutic Vucleic Acid Vaccine
By Application, Nucleic Acid Vaccine has been segmented into:
Hospital
Clinic
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Nucleic Acid Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Nucleic Acid Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Nucleic Acid Vaccine market.
The report offers in-depth assessment of the growth and other aspects of the Nucleic Acid Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Nucleic Acid Vaccine Market Share Analysis
Nucleic Acid Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Nucleic Acid Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Nucleic Acid Vaccine sales, revenue and market share for each player covered in this report.
The major players covered in Nucleic Acid Vaccine are:
Moderna
Zhifei Shengwu
Sanofi
CureVac
Hualan Bio
Inovio
BioKangtai
CNBG
GSK
Liaoning Chengda
CanSinoBIO
Walvax Biotechnology
Fosun Pharma
Among other players domestic and global, Nucleic Acid Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nucleic Acid Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nucleic Acid Vaccine, with price, sales, revenue and global market share of Nucleic Acid Vaccine in 2018 and 2019.
Chapter 3, the Nucleic Acid Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nucleic Acid Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Nucleic Acid Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Nucleic Acid Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Nucleic Acid Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Nucleic Acid Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Preventive Nucleic Acid Vaccine
1.2.3 Therapeutic Vucleic Acid Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global Nucleic Acid Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Overview of Global Nucleic Acid Vaccine Market
1.4.1 Global Nucleic Acid Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: Nucleic Acid Vaccine Industry Impact
1.6.1 COVID-19 Potential Implications for the Nucleic Acid Vaccine
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Nucleic Acid Vaccine
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 Moderna
2.1.1 Moderna Details
2.1.2 Moderna Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Moderna SWOT Analysis
2.1.4 Moderna Product and Services
2.1.5 Moderna Nucleic Acid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Zhifei Shengwu
2.2.1 Zhifei Shengwu Details
2.2.2 Zhifei Shengwu Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Zhifei Shengwu SWOT Analysis
2.2.4 Zhifei Shengwu Product and Services
2.2.5 Zhifei Shengwu Nucleic Acid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Sanofi SWOT Analysis
2.3.4 Sanofi Product and Services
2.3.5 Sanofi Nucleic Acid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 CureVac
2.4.1 CureVac Details
2.4.2 CureVac Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 CureVac SWOT Analysis
2.4.4 CureVac Product and Services
2.4.5 CureVac Nucleic Acid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Hualan Bio
2.5.1 Hualan Bio Details
2.5.2 Hualan Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Hualan Bio SWOT Analysis
2.5.4 Hualan Bio Product and Services
2.5.5 Hualan Bio Nucleic Acid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Inovio
2.6.1 Inovio Details
2.6.2 Inovio Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Inovio SWOT Analysis
2.6.4 Inovio Product and Services
2.6.5 Inovio Nucleic Acid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 BioKangtai
2.7.1 BioKangtai Details
2.7.2 BioKangtai Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 BioKangtai SWOT Analysis
2.7.4 BioKangtai Product and Services
2.7.5 BioKangtai Nucleic Acid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 CNBG
2.8.1 CNBG Details
2.8.2 CNBG Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 CNBG SWOT Analysis
2.8.4 CNBG Product and Services
2.8.5 CNBG Nucleic Acid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 GSK
2.9.1 GSK Details
2.9.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 GSK SWOT Analysis
2.9.4 GSK Product and Services
2.9.5 GSK Nucleic Acid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Liaoning Chengda
2.10.1 Liaoning Chengda Details
2.10.2 Liaoning Chengda Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Liaoning Chengda SWOT Analysis
2.10.4 Liaoning Chengda Product and Services
2.10.5 Liaoning Chengda Nucleic Acid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 CanSinoBIO
2.11.1 CanSinoBIO Details
2.11.2 CanSinoBIO Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 CanSinoBIO SWOT Analysis
2.11.4 CanSinoBIO Product and Services
2.11.5 CanSinoBIO Nucleic Acid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Walvax Biotechnology
2.12.1 Walvax Biotechnology Details
2.12.2 Walvax Biotechnology Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Walvax Biotechnology SWOT Analysis
2.12.4 Walvax Biotechnology Product and Services
2.12.5 Walvax Biotechnology Nucleic Acid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Fosun Pharma
2.13.1 Fosun Pharma Details
2.13.2 Fosun Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Fosun Pharma SWOT Analysis
2.13.4 Fosun Pharma Product and Services
2.13.5 Fosun Pharma Nucleic Acid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Nucleic Acid Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Nucleic Acid Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Nucleic Acid Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Nucleic Acid Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Nucleic Acid Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Nucleic Acid Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Nucleic Acid Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Nucleic Acid Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Nucleic Acid Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Nucleic Acid Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Nucleic Acid Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Nucleic Acid Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Nucleic Acid Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Nucleic Acid Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Nucleic Acid Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Nucleic Acid Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Nucleic Acid Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Nucleic Acid Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Nucleic Acid Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Nucleic Acid Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Nucleic Acid Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Nucleic Acid Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Nucleic Acid Vaccine Sales and Growth Rate (2015-2020)
6.4 France Nucleic Acid Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Nucleic Acid Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Nucleic Acid Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Nucleic Acid Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Nucleic Acid Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Nucleic Acid Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Nucleic Acid Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Nucleic Acid Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Nucleic Acid Vaccine Sales and Growth Rate (2015-2020)
7.5 India Nucleic Acid Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Nucleic Acid Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Nucleic Acid Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Nucleic Acid Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Nucleic Acid Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America Nucleic Acid Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Nucleic Acid Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Nucleic Acid Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Nucleic Acid Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Nucleic Acid Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Nucleic Acid Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Nucleic Acid Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Nucleic Acid Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Nucleic Acid Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Nucleic Acid Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Nucleic Acid Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Nucleic Acid Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Nucleic Acid Vaccine Price by Type (2015-2020)
11 Global Nucleic Acid Vaccine Market Segment by Application
11.1 Global Nucleic Acid Vaccine Sales Market Share by Application (2015-2020)
11.2 Global Nucleic Acid Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global Nucleic Acid Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Nucleic Acid Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Nucleic Acid Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America Nucleic Acid Vaccine Market Forecast (2021-2025)
12.2.2 Europe Nucleic Acid Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Nucleic Acid Vaccine Market Forecast (2021-2025)
12.2.4 South America Nucleic Acid Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Nucleic Acid Vaccine Market Forecast (2021-2025)
12.3 Nucleic Acid Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global Nucleic Acid Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global Nucleic Acid Vaccine Market Share Forecast by Type (2021-2025)
12.4 Nucleic Acid Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global Nucleic Acid Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global Nucleic Acid Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Nucleic Acid Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Nucleic Acid Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Nucleic Acid Vaccine Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Nucleic Acid Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Moderna Basic Information, Manufacturing Base and Competitors
Table 9. Moderna Nucleic Acid Vaccine Major Business
Table 10. Moderna Nucleic Acid Vaccine Total Revenue (USD Million) (2018-2019)
Table 11. Moderna SWOT Analysis
Table 12. Moderna Nucleic Acid Vaccine Product and Services
Table 13. Moderna Nucleic Acid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Zhifei Shengwu Basic Information, Manufacturing Base and Competitors
Table 15. Zhifei Shengwu Nucleic Acid Vaccine Major Business
Table 16. Zhifei Shengwu Nucleic Acid Vaccine Total Revenue (USD Million) (2018-2019)
Table 17. Zhifei Shengwu SWOT Analysis
Table 18. Zhifei Shengwu Nucleic Acid Vaccine Product and Services
Table 19. Zhifei Shengwu Nucleic Acid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Sanofi Basic Information, Manufacturing Base and Competitors
Table 21. Sanofi Nucleic Acid Vaccine Major Business
Table 22. Sanofi Nucleic Acid Vaccine Total Revenue (USD Million) (2018-2019)
Table 23. Sanofi SWOT Analysis
Table 24. Sanofi Nucleic Acid Vaccine Product and Services
Table 25. Sanofi Nucleic Acid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. CureVac Basic Information, Manufacturing Base and Competitors
Table 27. CureVac Nucleic Acid Vaccine Major Business
Table 28. CureVac Nucleic Acid Vaccine Total Revenue (USD Million) (2018-2019)
Table 29. CureVac SWOT Analysis
Table 30. CureVac Nucleic Acid Vaccine Product and Services
Table 31. CureVac Nucleic Acid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 33. Hualan Bio Nucleic Acid Vaccine Major Business
Table 34. Hualan Bio Nucleic Acid Vaccine Total Revenue (USD Million) (2018-2019)
Table 35. Hualan Bio SWOT Analysis
Table 36. Hualan Bio Nucleic Acid Vaccine Product and Services
Table 37. Hualan Bio Nucleic Acid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Inovio Basic Information, Manufacturing Base and Competitors
Table 39. Inovio Nucleic Acid Vaccine Major Business
Table 40. Inovio Nucleic Acid Vaccine Total Revenue (USD Million) (2018-2019)
Table 41. Inovio SWOT Analysis
Table 42. Inovio Nucleic Acid Vaccine Product and Services
Table 43. Inovio Nucleic Acid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. BioKangtai Basic Information, Manufacturing Base and Competitors
Table 45. BioKangtai Nucleic Acid Vaccine Major Business
Table 46. BioKangtai Nucleic Acid Vaccine Total Revenue (USD Million) (2018-2019)
Table 47. BioKangtai SWOT Analysis
Table 48. BioKangtai Nucleic Acid Vaccine Product and Services
Table 49. BioKangtai Nucleic Acid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. CNBG Basic Information, Manufacturing Base and Competitors
Table 51. CNBG Nucleic Acid Vaccine Major Business
Table 52. CNBG Nucleic Acid Vaccine Total Revenue (USD Million) (2018-2019)
Table 53. CNBG SWOT Analysis
Table 54. CNBG Nucleic Acid Vaccine Product and Services
Table 55. CNBG Nucleic Acid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. GSK Basic Information, Manufacturing Base and Competitors
Table 57. GSK Nucleic Acid Vaccine Major Business
Table 58. GSK Nucleic Acid Vaccine Total Revenue (USD Million) (2018-2019)
Table 59. GSK SWOT Analysis
Table 60. GSK Nucleic Acid Vaccine Product and Services
Table 61. GSK Nucleic Acid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Liaoning Chengda Basic Information, Manufacturing Base and Competitors
Table 63. Liaoning Chengda Nucleic Acid Vaccine Major Business
Table 64. Liaoning Chengda Nucleic Acid Vaccine Total Revenue (USD Million) (2018-2019)
Table 65. Liaoning Chengda SWOT Analysis
Table 66. Liaoning Chengda Nucleic Acid Vaccine Product and Services
Table 67. Liaoning Chengda Nucleic Acid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. CanSinoBIO Basic Information, Manufacturing Base and Competitors
Table 69. CanSinoBIO Nucleic Acid Vaccine Major Business
Table 70. CanSinoBIO Nucleic Acid Vaccine Total Revenue (USD Million) (2018-2019)
Table 71. CanSinoBIO SWOT Analysis
Table 72. CanSinoBIO Nucleic Acid Vaccine Product and Services
Table 73. CanSinoBIO Nucleic Acid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. Walvax Biotechnology Basic Information, Manufacturing Base and Competitors
Table 75. Walvax Biotechnology Nucleic Acid Vaccine Major Business
Table 76. Walvax Biotechnology Nucleic Acid Vaccine Total Revenue (USD Million) (2018-2019)
Table 77. Walvax Biotechnology SWOT Analysis
Table 78. Walvax Biotechnology Nucleic Acid Vaccine Product and Services
Table 79. Walvax Biotechnology Nucleic Acid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 80. Fosun Pharma Basic Information, Manufacturing Base and Competitors
Table 81. Fosun Pharma Nucleic Acid Vaccine Major Business
Table 82. Fosun Pharma Nucleic Acid Vaccine Total Revenue (USD Million) (2018-2019)
Table 83. Fosun Pharma SWOT Analysis
Table 84. Fosun Pharma Nucleic Acid Vaccine Product and Services
Table 85. Fosun Pharma Nucleic Acid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 86. Global Nucleic Acid Vaccine Sales by Manufacturer (2018-2019) (K Units)
Table 87. Global Nucleic Acid Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 88. Global Nucleic Acid Vaccine Sales by Regions (2015-2020) (K Units)
Table 89. Global Nucleic Acid Vaccine Sales Market Share by Regions (2015-2020)
Table 90. Global Nucleic Acid Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 91. North America Nucleic Acid Vaccine Sales by Countries (2015-2020) (K Units)
Table 92. North America Nucleic Acid Vaccine Sales Market Share by Countries (2015-2020)
Table 93. North America Nucleic Acid Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 94. North America Nucleic Acid Vaccine Revenue Market Share by Countries (2015-2020)
Table 95. Europe Nucleic Acid Vaccine Sales by Countries (2015-2020) (K Units)
Table 96. Europe Nucleic Acid Vaccine Sales Market Share by Countries (2015-2020)
Table 97. Europe Nucleic Acid Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 98. Asia-Pacific Nucleic Acid Vaccine Sales by Regions (2015-2020) (K Units)
Table 99. Asia-Pacific Nucleic Acid Vaccine Sales Market Share by Regions (2015-2020)
Table 100. Asia-Pacific Nucleic Acid Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 101. South America Nucleic Acid Vaccine Sales by Countries (2015-2020) (K Units)
Table 102. South America Nucleic Acid Vaccine Sales Market Share by Countries (2015-2020)
Table 103. South America Nucleic Acid Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 104. South America Nucleic Acid Vaccine Revenue Market Share by Countries (2015-2020)
Table 105. Middle East & Africa Nucleic Acid Vaccine Sales by Countries (2015-2020) (K Units)
Table 106. Middle East & Africa Nucleic Acid Vaccine Sales Market Share by Countries (2015-2020)
Table 107. Middle East & Africa Nucleic Acid Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 108. Middle East & Africa Nucleic Acid Vaccine Revenue Market Share by Countries (2015-2020)
Table 109. Global Nucleic Acid Vaccine Sales by Type (2015-2020) (K Units)
Table 110. Global Nucleic Acid Vaccine Sales Share by Type (2015-2020)
Table 111. Global Nucleic Acid Vaccine Revenue by Type (2015-2020) (USD Million)
Table 112. Global Nucleic Acid Vaccine Revenue Share by Type (2015-2020)
Table 113. Global Nucleic Acid Vaccine Sales by Application (2015-2020) (K Units)
Table 114. Global Nucleic Acid Vaccine Sales Share by Application (2015-2020)
Table 115. Global Nucleic Acid Vaccine Sales Forecast by Regions (2021-2025) (K Units)
Table 116. Global Nucleic Acid Vaccine Market Share Forecast by Regions (2021-2025)
Table 117. Global Nucleic Acid Vaccine Sales Forecast by Type (2021-2025) (K Units)
Table 118. Global Nucleic Acid Vaccine Market Share Forecast by Type (2021-2025)
Table 119. Global Nucleic Acid Vaccine Sales Forecast by Application (2021-2025)
Table 120. Global Nucleic Acid Vaccine Market Share Forecast by Application (2021-2025)
Table 121. Direct Channel Pros & Cons
Table 122. Indirect Channel Pros & Cons
Table 123. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Nucleic Acid Vaccine Picture
Figure 2. Global Sales Market Share of Nucleic Acid Vaccine by Type in 2019
Figure 3. Preventive Nucleic Acid Vaccine Picture
Figure 4. Therapeutic Vucleic Acid Vaccine Picture
Figure 5. Nucleic Acid Vaccine Sales Market Share by Application in 2018
Figure 6. Hospital Picture
Figure 7. Clinic Picture
Figure 8. Others Picture
Figure 9. Global Nucleic Acid Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Nucleic Acid Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Nucleic Acid Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Nucleic Acid Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Nucleic Acid Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Nucleic Acid Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Nucleic Acid Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Nucleic Acid Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Nucleic Acid Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Nucleic Acid Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Nucleic Acid Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Nucleic Acid Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Nucleic Acid Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Nucleic Acid Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Nucleic Acid Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Nucleic Acid Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Nucleic Acid Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Nucleic Acid Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Nucleic Acid Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Nucleic Acid Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Nucleic Acid Vaccine Sales Market Share by Manufacturer in 2019
Figure 30. Global Nucleic Acid Vaccine Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Nucleic Acid Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Nucleic Acid Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Nucleic Acid Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Nucleic Acid Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Nucleic Acid Vaccine Revenue Market Share by Regions (2015-2020)
Figure 37. Global Nucleic Acid Vaccine Revenue Market Share by Regions in 2018
Figure 38. North America Nucleic Acid Vaccine Sales and Growth Rate (2015-2020)
Figure 39. Europe Nucleic Acid Vaccine Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Nucleic Acid Vaccine Sales and Growth Rate (2015-2020)
Figure 41. South America Nucleic Acid Vaccine Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Nucleic Acid Vaccine Sales and Growth Rate (2015-2020)
Figure 43. North America Nucleic Acid Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Nucleic Acid Vaccine Sales Market Share by Countries (2015-2020)
Figure 45. North America Nucleic Acid Vaccine Sales Market Share by Countries in 2018
Figure 46. North America Nucleic Acid Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Nucleic Acid Vaccine Revenue Market Share by Countries in 2018
Figure 48. United States Nucleic Acid Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Nucleic Acid Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Nucleic Acid Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Nucleic Acid Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Nucleic Acid Vaccine Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Nucleic Acid Vaccine Revenue Market Share by Countries in 2019
Figure 54. Germany Nucleic Acid Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Nucleic Acid Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Nucleic Acid Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Nucleic Acid Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Nucleic Acid Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Nucleic Acid Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Nucleic Acid Vaccine Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Nucleic Acid Vaccine Revenue Market Share by Regions 2019
Figure 62. China Nucleic Acid Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Nucleic Acid Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Nucleic Acid Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Nucleic Acid Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Nucleic Acid Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Nucleic Acid Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Nucleic Acid Vaccine Sales Market Share by Countries in 2019
Figure 69. South America Nucleic Acid Vaccine Revenue Market Share by Countries in 2019
Figure 70. Brazil Nucleic Acid Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Nucleic Acid Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Nucleic Acid Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Nucleic Acid Vaccine Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Nucleic Acid Vaccine Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Nucleic Acid Vaccine Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Nucleic Acid Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Nucleic Acid Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Nucleic Acid Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Nucleic Acid Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Nucleic Acid Vaccine Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Nucleic Acid Vaccine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Nucleic Acid Vaccine Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Nucleic Acid Vaccine Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Nucleic Acid Vaccine Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Nucleic Acid Vaccine Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Nucleic Acid Vaccine Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
核ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Nucleic Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…- 核酸ゲル染色剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Nucleic Acid Gel Stains market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Nucleic Acid Gel Stai…
- 核酸定量キットの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Nucleic Acid Quantitation Kit market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Nucleic Acid Qu…
- 自動核酸抽出システムの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Automated Nucleic Acid Extraction Systems market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Aut…
- 新型コロナウイルス感染症核酸検査キットの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global COVID-19 Nucleic Acid Testing Kits market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The COVID-19 N…